EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 8 filers reported holding EXELIXIS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,934,091 | +205.8% | 132,411 | +164.1% | 0.00% | +200.0% |
| Q2 2023 | $959,333 | +4.1% | 50,135 | +4.2% | 0.00% | 0.0% |
| Q1 2023 | $921,151 | -71.4% | 48,127 | -76.5% | 0.00% | -75.0% |
| Q4 2022 | $3,222,100 | +2.7% | 204,448 | +3.3% | 0.00% | -20.0% |
| Q3 2022 | $3,138,000 | +257.4% | 197,934 | +372.4% | 0.01% | +400.0% |
| Q2 2022 | $878,000 | +40.5% | 41,902 | +52.3% | 0.00% | 0.0% |
| Q1 2022 | $625,000 | +105.6% | 27,517 | +67.2% | 0.00% | – |
| Q4 2021 | $304,000 | -54.7% | 16,460 | -47.7% | 0.00% | -100.0% |
| Q3 2021 | $671,000 | -32.3% | 31,474 | -42.0% | 0.00% | 0.0% |
| Q2 2021 | $991,000 | +50.2% | 54,223 | +86.8% | 0.00% | 0.0% |
| Q1 2021 | $660,000 | +77.9% | 29,030 | +56.1% | 0.00% | – |
| Q4 2020 | $371,000 | -46.4% | 18,603 | -34.2% | 0.00% | -100.0% |
| Q3 2020 | $692,000 | +54.5% | 28,254 | +49.7% | 0.00% | 0.0% |
| Q2 2020 | $448,000 | -34.8% | 18,868 | -52.1% | 0.00% | -50.0% |
| Q1 2020 | $687,000 | +3.3% | 39,359 | +5.3% | 0.00% | +100.0% |
| Q4 2019 | $665,000 | -52.4% | 37,387 | -36.4% | 0.00% | -66.7% |
| Q1 2019 | $1,398,000 | +78.8% | 58,755 | +46.9% | 0.00% | +200.0% |
| Q4 2018 | $782,000 | -70.1% | 40,000 | -72.9% | 0.00% | -75.0% |
| Q3 2018 | $2,617,000 | -33.7% | 147,865 | +13.9% | 0.00% | -33.3% |
| Q4 2017 | $3,948,000 | +576.0% | 129,871 | +231.6% | 0.01% | +500.0% |
| Q4 2016 | $584,000 | +3793.3% | 39,168 | +281.0% | 0.00% | – |
| Q4 2014 | $15,000 | -80.8% | 10,280 | -55.0% | 0.00% | – |
| Q2 2014 | $78,000 | -3.7% | 22,829 | +0.0% | 0.00% | – |
| Q1 2014 | $81,000 | -36.7% | 22,828 | +9.8% | 0.00% | – |
| Q4 2013 | $128,000 | -85.6% | 20,800 | -86.4% | 0.00% | -100.0% |
| Q3 2013 | $888,000 | -38.8% | 152,644 | -52.2% | 0.00% | -50.0% |
| Q2 2013 | $1,451,000 | -1.8% | 319,644 | 0.0% | 0.00% | -20.0% |
| Q1 2013 | $1,477,000 | -14.0% | 319,644 | -14.9% | 0.01% | -28.6% |
| Q4 2012 | $1,717,000 | -5.2% | 375,800 | 0.0% | 0.01% | 0.0% |
| Q3 2012 | $1,811,000 | -57.4% | 375,800 | -51.1% | 0.01% | -63.2% |
| Q2 2012 | $4,251,000 | +6.7% | 768,800 | 0.0% | 0.02% | +11.8% |
| Q1 2012 | $3,983,000 | – | 768,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |